Spyre Therapeutics
SYRE
SYRE
131 hedge funds and large institutions have $1.39B invested in Spyre Therapeutics in 2024 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 63 increasing their positions, 20 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
10% more funds holding
Funds holding: 119 → 131 (+12)
1.11% more ownership
Funds ownership: 100.89% → 102% (+1.1%)
8% less capital invested
Capital invested by funds: $1.51B → $1.39B (-$118M)
Holders
131
Holding in Top 10
4
Calls
$161K
Puts
$79K
Top Buyers
| 1 | +$49.3M | |
| 2 | +$27.4M | |
| 3 | +$17.7M | |
| 4 |
BlackRock
New York
|
+$17.1M |
| 5 |
Goldman Sachs
New York
|
+$13.5M |
Top Sellers
| 1 | -$26.1M | |
| 2 | -$18.2M | |
| 3 | -$17.6M | |
| 4 |
Walleye Capital
New York
|
-$7.16M |
| 5 |
PA
Perceptive Advisors
New York
|
-$6.93M |